文献速递主动脉疾病

胸主动脉腔内修复对钝性创伤性主动脉损伤患者主动脉形态的影响:多中心研究长期结果

Influence of Thoracic Endovascular Repair on Aortic Morphology in Patients Treated for Blunt Traumatic Aortic Injuries: Long Term Outcomes in a Multicentre Study.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2020-01-03

本研究为回顾性多中心观察研究,评估钝性创伤性主动脉损伤(BTAI)患者行胸主动脉腔内修复(TEVAR)后的主动脉重塑及相关并发症。共52例患者接受治疗,47例纳入重塑分析,中位随访67.4个月,1、3、6、10年生存率分别为90.4%、88.3%、84.8%、84.8%。TEVAR中远期安全,重塑与时间、oversizing及封堵 zone 2 相关,但不良事件少。

要点

  • TEVAR治疗BTAI中远期安全,无手术/移植物相关并发症,仅1例晚期壁内血肿需再干预。
  • 主动脉重塑发生率随时间增加,1、6、10年免于重塑率分别为85.1%、30.9%、24.7%。
  • 近端和远端直径增加与时间、年龄及zone 2封堵相关,oversizing每增加10%近端重塑增加3.4%。

核心结论

  • TEVAR用于BTAI中远期安全,主动脉重塑与时间、oversizing及封堵zone 2相关,但不良事件发生率低。

研究设计与样本

  • 回顾性、观察性、多中心研究,2004至2017年共52例BTAI患者接受TEVAR,47例纳入重塑分析(排除5例早期死亡),中位年龄47岁(范围20-80岁)。

主要发现

  • 平均TEVAR oversizing为19.6%±9.7%(范围5%-35%),中位随访67.4±56.1个月(范围14-153个月)。
  • 1、3、6、10年生存率分别为90.4%(SE 4.1%)、88.3%(SE 4.5%)、84.8%(SE 5.5%)、84.8%(SE 5.5%)。
  • 除1例晚期壁内血肿需再干预外,无手术/移植物相关并发症。
  • 1、6、10年免于主动脉重塑率分别为85.1%(SE 5.2%)、30.9%(SE 8.6%)、24.7%(SE 8.8%)。
  • D1/D2和D3直径增加受干预时间(均p < .001)、年龄(p < .001和p = .002)及zone 2封堵(p = .027和p = .042)影响;oversizing每增加10%,近端瘤颈直径重塑增加3.4%(p = .05);远端轴线随时间减小(p < .001,3至6年间显著)。

临床怎么用

  • 对BTAI行TEVAR后应长期影像随访监测主动脉重塑,尤其关注oversizing较大及zone 2封堵的患者。

局限性

  • 回顾性观察性设计,样本量较小(47例分析),随访时间不一,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to evaluate aortic remodelling and associated complications in patients treated by thoracic endovascular aneurysm repair (TEVAR) for blunt traumatic aortic injuries (BTAI). METHODS: This was a retrospective, observational, multicentre study. Remodelling was considered as aortic diameter variations of >2 mm and distal graft and aortic axis angle modification measured by computed tomography angiography (CTA). The predefined levels of measurement were the proximal end of the graft (D1: landing in zone [LZ] 2; D2: LZ 3); distal end (D3); and control measurement (D4) 15 mm beyond D3. Survival, procedure, graft, and/or radiation exposure related complications were registered. CTA was required within three months and at one, six, and 10 years post-operatively. RESULTS: Between 2004 and 2017 52 patients were treated; 47 were included for remodelling analysis (five immediate deaths were excluded); median age was 47 years (range 20-80 years). Mean TEVAR oversizing was 19.6% ± 9.7% (range 5%-35%). Following a median follow up of 67.4 ± 56.1 months (range 14-153 months) survival at one, three, six, and 10 years was 90.4% (standard error [SE] 4.1%), 88.3% (SE 4.5%) 84.8% (SE 5.5%), and 84.8% (SE 5.5%), respectively. There were no procedure/graft related complications except for one late intramural haematoma that required re-intervention. Freedom from aortic remodelling at one, six, and 10 years was 85.1% (SE 5.2%), 30.9% (SE 8.6%), and 24.7% (SE 8.8%), respectively. The increase in D1/D2 and D3 diameters were influenced by time from intervention (both p < .001), age (p < .001 and p = .002, respectively) and sealing in zone 2 (p = .027 and p = .042, respectively). For every 10% increase in oversizing, proximal neck diameter remodelling was 3.4% (p = .05). The distal axis decreased over time (p < .001; significant between three and six years). CONCLUSION: TEVAR is safe for BTAI in the mid to long term. This study reports a correlation between time, oversizing, and remodelling, but the level of adverse events was low.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Gennai S, Leone N, Andreoli F, et al. Influence of Thoracic Endovascular Repair on Aortic Morphology in Patients Treated for Blunt Traumatic Aortic Injuries: Long Term Outcomes in a Multicentre Study. Eur J Vasc Endovasc Surg. 2020. PMID: 31911139. doi:10.1016/j.ejvs.2019.05.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。